A Prospective, Multi-center Study to Evaluate the Efficacy and Safety of Vitamin D3 B.O.N. Intramuscular Injection in Adults With Vitamin D Deficiency
A Prospective, Multi-centre, Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Vitamin D3 B.O.N. Intramuscular Injection in Adults With Vitamin D Deficiency
1 other identifier
interventional
84
0 countries
N/A
Brief Summary
To compare the efficacy of Vitamin D3 B.O.N. Intramuscular Injection within 12 weeks with that of placebo in adults with Vitamin D Deficiency.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Nov 2014
Shorter than P25 for phase_3
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2014
CompletedFirst Submitted
Initial submission to the registry
May 11, 2015
CompletedFirst Posted
Study publicly available on registry
May 13, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedJuly 27, 2016
July 1, 2016
9 months
May 11, 2015
July 25, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Primary Efficacy Endpoints (serum 25(OH)D concentration)
serum 25(OH)D concentration
12 weeks
Secondary Outcomes (1)
Secondary Efficacy Endpoints (serum 25(OH)D concentration)
24 weeks
Study Arms (2)
Vitamin D deficiency
EXPERIMENTALGroup 1
Vitamin D deficiency (Low)
EXPERIMENTALGroup 2
Interventions
Eligibility Criteria
You may qualify if:
- Subjects with vitamin D deficiency
You may not qualify if:
- Subjects who experienced a hypersensitivity to the cholecalciferol
- Subjects with renal impairment
- Subjects with Hypercalcemia
- Subjects with Hypercalciuria
- Subjects with clinically doubted calcium stone
- Subjects diagnosed with sarcoidosis
- Subjected diagnosed with pseudo-hypoparathyroidism
- Subjected with malignancy
- Subjects with clinically significant cardiovascular or lung impairment Judged by the investigator
- Subjects with the below laboratory abnormality (Platelet, WBC, Absolute neutrophil count, Albumin, AST or ALT)
- Subjects who are to take vitamin D supplements during the study period
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sung-Kil Lim, Professor
Severance Hospital Seoul, Korea
- PRINCIPAL INVESTIGATOR
Yun-seok Jeong, Professor
Ajou University Hospital, Korea
- PRINCIPAL INVESTIGATOR
Han-seok Choi, Professor
Dongguk University Ilsan Hospital, Korea
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 11, 2015
First Posted
May 13, 2015
Study Start
November 1, 2014
Primary Completion
August 1, 2015
Study Completion
December 1, 2015
Last Updated
July 27, 2016
Record last verified: 2016-07